Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Analytical Procedures

A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay

Teppei Arai, Hidetaka Majima, Akira Watanabe, Katsuhiko Kamei
Teppei Arai
aMedical Mycology Research Center, Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidetaka Majima
aMedical Mycology Research Center, Chiba University, Chiba, Japan
bDepartment of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Watanabe
aMedical Mycology Research Center, Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsuhiko Kamei
aMedical Mycology Research Center, Chiba University, Chiba, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.02271-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

One of the main mechanisms of azole resistance of Aspergillus fumigatus is thought to be a reduction in the drug’s affinity for the target molecule, Cyp51A, due to its amino acid mutation(s). It is known that the azole resistance pattern is closely related to the mutation site(s) of the molecule. In this study, we tried to develop a simple and rapid detection method for cyp51A mutations using the endonuclease Surveyor nuclease. The Surveyor nuclease assay was verified using several azole-resistant strains of A. fumigatus that possess point mutations in Cyp51A. For validation of the Surveyor nuclease assay, blind tests were conducted using 48 strains of A. fumigatus (17 azole-resistant and 31 azole-susceptible strains). The Surveyor nuclease assay could rapidly detect cyp51A mutations with one primer set. Also, all the tested strains harboring different cyp51A single point mutations could be clearly distinguished from the wild type. The Surveyor nuclease assay is a simple method that can detect cyp51A mutations rapidly.

INTRODUCTION

Azole antifungals are widely regarded as first-line therapeutic drugs for invasive aspergillosis. The increase of azole-resistant Aspergillus fumigatus strains in recent years has become a serious problem worldwide (1). The target of azoles is 14α-sterol demethylase, involved in ergosterol biosynthesis, and most azole-resistant A. fumigatus strains have mutations in cyp51A, which encodes the enzyme (2). The Cyp51A molecule with point mutations in hot spots lowered the binding affinity for azole drugs, resulting in azole resistance in the strain (3). Hot spots that confer resistance have been reported, such as mutations at positions glycine 54, glycine 138, proline 216, methionine 220, and glycine 448 (4–9). A point mutation in Cyp51A can occur in some hosts receiving long-term azole therapy. On the other hand, azole-resistant A. fumigatus derived from exposure to azole fungicides in the environment has also been reported (10–12). The cyp51A genes of these environmental strains mostly have a tandem repeat (TR) in the promoter region and a point mutation(s) in the open reading frame. Typically, TR34 (tandem repeat sequence of 34 base pairs) and TR46 are combined with L98H and Y121F/T289A mutations, respectively. Recently, the TR53 azole resistance mechanism has also been reported (13). In addition, five single nucleotide polymorphism (SNP) cyp51A mutations (F46Y, M172V, N248T, D255E, and E427K) in A. fumigatus have been reported worldwide (14–18). These strains are not usually defined as resistant but often have relatively high MICs of azoles compared with the wild type. Furthermore, strains with 3 SNPs (F46Y, M172V, and E427K) that show the same intermediate susceptibility profile for azole drugs have been described (14–18).

In these situations, a rapid detection method for mutations in cyp51A would prove to be a promising tool for the early, adequate treatment of aspergillosis and would be an appropriate epidemiological survey for azole-resistant A. fumigatus. Several methods have been developed to rapidly detect mutations in cyp51A in A. fumigatus. Some methods are based on the LightCycler instrument using a TaqMan assay or melting curve analysis (19–21), and a method using loop-mediated isothermal amplification has also been developed (22).

Surveyor nuclease (SN) (Integrated DNA Technologies, Inc.) is a member of a family of plant endonucleases that cleave heteroduplex DNA with high specificity at sites of base substitution mismatch and DNA distortion. The assay using the enzyme is used to confirm the presence or absence of mutation introduction in genome-editing experiments (TALE nuclease, CRISPR/Cas9, etc.) (23–25). In another study, the SN assay was used to screen for mutations in kidney-related genes. In that study, it was shown that the SN assay could detect a high percentage of DNA variations rapidly and at low cost (26).

In the current study, we show that the SN assay is useful for detecting mutations in cyp51A in A. fumigatus.

RESULTS

cyp51A mutation discrimination by SN assay.As a test sample, genomic DNA of A. fumigatus with a G54W mutation in cyp51A was used, and the SN treatment time was from 20 to 60 min (Fig. 1). Samples treated for 20 and 30 min could clearly confirm the cleavage fragments. Cleavage fragments treated for more than 40 min gradually became less clear. Based on this result, SN treatment was conducted for 30 min in the subsequent experiments. The results of the search for major mutations are shown in Fig. 2. The expected cleavage fragments were confirmed in G54, M220, G448S, and L98H samples. However, in the Y121F/T289A sample, an uncleaved fragment (704 plus 503 bp and 454 plus 503 bp) was also observed. In samples with 5 SNPs, a band pattern different from the others was detected. Samples on which colony direct PCR was performed (strains carrying cyp51A with a G54W [IFM 63345] or M220V [IFM64304] mutation) also provided the same results as the experiment using genomic DNA as a template (see Fig. S1 in the supplemental material).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Efficiency of cleavage by SN. The 1,661-bp amplicons were PCR amplified. The G54W mutant amplicon was annealed in combination with the reference amplicon (wild-type cyp51A). SN treatment was performed at 42°C for 20, 30, 40, 50, and 60 min. The cleavage products were 1,480 and 181 bp. The control was annealed alone with the reference amplicon.

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Detection of major mutations by SN. Six major mutations were tested by SN assay. (a) Detection patterns of the G54 mutation. Lane 1, control; lane 2, G54W (cleavage fragments, 181 and 1,480 bp); lane 3, G54R (181 and 1,480 bp); lane 4 G54V (182 and 1,479 bp). (b) Detection patterns of the M220 mutation. Lane 5, control; lane 6, M220K (fragments, 751 and 910 bp); lane 7, M220I (752 and 909 bp); lane 8, M220V (750 and 911 bp). (c) Detection patterns of Y120F/T289A (lane 10; the fragments were 454, 503, and 704 bp), G448S (lane 11; 227 and 1,434 bp), and L98H (lane 12; 385 and 1,276 bp) mutations. In the Y120F/T289A lane, incomplete cleavage fragments (957 and 1,207 bp) can be observed. Lane 9, control. (d) Lane 14, 5SNP (Af293) detection pattern (many cleavage fragments were detected); lane 13, control.

Validation of the SN assay.Blind tests were conducted to verify the SN assay for the detection of cyp51A mutations. The test was performed on 17 azole-resistant and 31 azole-susceptible strains. All the resistant strains used in the test had mutations in cyp51A and could be distinguished from susceptible strains (see Table S1 in the supplemental material). Mutations were detected in 4 sensitive strains in which the sequence of cyp51A was not analyzed. Of these, 3 strains had N248K and 1 strain had M39I mutations.

DISCUSSION

The amino acid mutations in Cyp51A have been reported to be a major cause of the reduction of drug affinity for the molecule, which is the leading cause of azole resistance in A. fumigatus (3). It is also known that azole resistance shows different patterns correlated with the mutated amino acid sites (4–9). Therefore, rapid determination of the mutation pattern in the Cyp51A molecule should be useful for selecting the appropriate treatment for aspergillosis. For example, G54 and P216 mutant strains are susceptible to voriconazole (VRCZ), and TR34/L98H strains are multi-azole resistant (4–9). In addition, such a method would be suitable for performing epidemiological studies, such as evaluating the rate of azole-resistant A. fumigatus or extracting strains potentially having various or unknown mutations in cyp51A from among a large number of environmental or clinical isolates for screening.

In this study, we developed a novel method for detecting point mutations in the cyp51A gene using the SN assay. The assay could clearly distinguish wild-type cyp51A from point-mutated genes. The assay is able to reduce the time needed to determine the presence or absence of mutations. In addition, various mutations in the gene can be detected with only one primer set, and moreover, unknown mutations in the target region can also be detected. In fact, an unreported mutation, M39I, was detected in this study, although it is not related to azole resistance. Based on the above, the SN assay is suitable for primary screening analysis to extract isolates possessing point mutations from a large number of A. fumigatus strains.

Several methods have previously been developed for the detection of mutations that confer azole resistance (19–22). Most of them require different assays for specific mutations. On the other hand, the SN assay is characterized as being able to detect different mutations with only one primer set that amplifies the cyp51A gene region. In addition, mutations can be detected directly from a fungal colony because the SN assay can be performed when the target region of the sample is amplified using colony direct PCR. Therefore, the time required for extracting DNA can be shortened considerably. With the SN assay, sequence analysis by the Sanger method is necessary to determine the detailed mutation site. However, known mutations, such as G54, M220, and G448, can be assumed from the size of the cleaved fragment. On the other hand, many SNPs in the cyp51A gene that do not confer azole resistance have been reported (19). If these sites are close to mutations that cause azole resistance, it is difficult to differentiate restriction fragments in an electrophoresis gel. Recently, A. fumigatus strains having cyp51A with 5 amino acid mutations (F46Y, M172V, N248T, D255E, and E427K), termed 5SNPs, have been reported (14–18). The strains with cyp51A with 5SNPs usually have higher azole MICs. Since the 5SNPs have 3 silent mutations (G89G, L358L, and C454C), the gene encoding the 5SNPs has many mutations. In the SN assay, the 5SNPs can be identified by the pattern of characteristic cleavage fragments.

In conclusion, this is the first study using the SN assay for detection of cyp51A changes in A. fumigatus. The assay is a simple method by which mutations in the cyp51A gene of A. fumigatus can be rapidly detected with only one primer set. Using this method, the time required to obtain information regarding the mutations in azole-resistant strains can be shortened. The assay can be performed if one target gene of the specimen is amplified by PCR. Therefore, the SN assay is indeed a promising method that can be readily applied to, e.g., the detection of mutations that confer resistance in other fungal species. In future work, it will be necessary to develop technology to detect cyp51A mutations directly from clinical samples using the SN assay.

MATERIALS AND METHODS

Strains.Forty-eight characterized A. fumigatus clinical strains, A1163 (= IFM 53842), and Af293 (= IFM 54229) were provided through the National Bio-Resource Project (NBRP) Japan (http://www.nbrp.jp/). A1163 was used as a reference strain of Cyp51A (AFUB_063960), and Af293 was used as a strain having 5 SNPs of Cyp51A (AFUA_4G06890). Antifungal susceptibility testing had already been performed according to the Clinical and Laboratory Standards Institute reference broth microdilution method, document M38, with partial modifications (27). Briefly, tests were performed in triplicate with itraconazole (ITCZ) and VRCZ in RPMI 1640 medium (pH 7.0) at 35°C using a dried plate for antifungal susceptibility testing (Eiken Chemicals, Tokyo, Japan). In some strains, susceptibility test results were read on the 3rd day because of their slow growth. Among the 48 clinical strains, 17 were azole resistant and 31 were azole susceptible. The cyp51A sequences of all the azole-resistant strains had been analyzed previously, and all of them were confirmed to possess a mutation(s) in cyp51A (see Table S1). Also, five azole-susceptible strains had been analyzed previously, and no mutations were found in cyp51A.

DNA extraction.Genome DNA was extracted from overnight-cultured mycelia by the urea-phenol method. Mycelia were mixed with 0.5-mm glass beads, 0.5 ml phenol-chloroform-isoamyl alcohol (PCI), and 0.5 ml DNA extraction buffer (50 mM Tris-HCl, pH 8.0, 20 mM EDTA, 0.3 M NaCl, 0.5% SDS, 5 M urea) and disrupted with a beads musher (FastPrep FP100A; MP-Biomedicals, Santa Ana, CA). After centrifugation, the upper layer was transferred to a new tube and subjected to ethanol precipitation. The resulting DNA pellet was suspended in 100 μl Tris-EDTA (TE) buffer.

Amplification of the cyp51A region.The cyp51A gene region was amplified from genome DNA by PCR using the primer set cyp51A_AF2P_F (5′-CCCTCCCTGTGTCTCCTCGAA-3′) and cyp51A_AF4P_R (5′-TCCTCGATGGTTACAACAGTCTCAC-3′). Amplification was carried out using KOD FX Neo (Toyobo Co., Ltd., Osaka, Japan). The amplification was carried out with an initial denaturation at 94°C for 2 min, followed by 30 cycles of 98°C for 10 s, 57°C for 30 s, and 68°C for 1 min, with a final extension at 68°C for 1 min. PCR products were purified with a Fast Gene gel/PCR extraction kit (Nippon Genetics Co., Ltd., Tokyo, Japan). The purification step was added in this study to determine the exact concentration of PCR amplicon. As a reference DNA, cyp51A of Fungal Genetics Stock Center (FGSC) strain A1163 (= IFM 53842) incorporated in the plasmid pUC119 was used. Colony direct PCR was performed using fungal cells cultured for 48 h at 37°C on a peptone-dextrose agar (PDA) plate. A few mycelia were added to the reaction mixture, and the cyp51A region was amplified with KOD FX Neo.

DNA hybridization.In a total volume of 10 μl, 250 ng each of the test and reference PCR amplicons, 1 μl 10× buffer (100 mM Tris-HCl, pH 8.0, 15 mM MgCl2, 500 mM KCl), and distilled water were mixed. As a control, 500 ng of the reference PCR amplicon was used. The mixture was heated to 95°C for 10 min for denaturing, followed by a slow reduction in temperature until a temperature of 25°C was reached. This reaction was performed using a thermal cycler (95°C for 10 min, 85°C for 90 s, 75°C for 90 s, 65°C for 90 s, 55°C for 90 s, 45°C for 90 s, 35°C for 90 s, and 25°C for 90 s). Then, the sample was stored at 4°C until the next step.

Treatment with SN.A Surveyor mutation detection kit was purchased from Integrated DNA Technologies (Coralville, IA, USA); 10 μl hybridized sample, 1 μl Surveyor nuclease S, 1 μl Surveyor enhancer S, and 1.3 μl 0.15 mM MgCl2 were mixed. The reaction mixtures were incubated at 42°C for 20, 30, 40, 50, or 60 min. After incubation, 1.5 μl of stop solution was added.

Analysis of DNA fragments.Analysis of DNA fragments was performed by agarose gel electrophoresis using 2% agarose and 1× Tris-acetate-EDTA (TAE) and then by staining with ethidium bromide.

Blind test for validation of the SN assay.A blind test was conducted with the 48 strains (see Table S1). Among the strains used, the cyp51A sequences of 5 susceptible strains and 17 resistant strains had been analyzed previously. The remaining 26 susceptible strains used were those whose cyp51A sequences had not been analyzed before the blind test. After determining the presence or absence of mutations by SN assay, the cyp51A sequences of these strains were analyzed. 

Sequence analysis.The nucleotide sequences of DNA fragments were determined using BigDye Terminator v1.1/3.1 (Applied Biosystems, Tokyo, Japan) and an ABI automatic sequencer (PerkinElmer, Tokyo, Japan). The primers for DNA sequencing are shown in Table S2 in the supplemental material.

Data availability.All the data analyzed during this study are included here and in the supplemental material.

ACKNOWLEDGMENTS

This research was supported by AMED under grants no. JP19jm0110015, 19fm0208024, and JP19fk0108094.

We have no conflict of interest to declare.

FOOTNOTES

    • Received 12 November 2019.
    • Returned for modification 15 December 2019.
    • Accepted 22 January 2020.
    • Accepted manuscript posted online 3 February 2020.
  • Supplemental material is available online only.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Chowdhary A,
    2. Sharma C,
    3. Meis JF
    . 2017. Azole-resistant aspergillosis: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216:S436–S444. doi:10.1093/infdis/jix210.
    OpenUrlCrossRef
  2. 2.↵
    1. Hagiwara D,
    2. Watanabe A,
    3. Kamei K,
    4. Goldman GH
    . 2016. Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus fungi. Front Microbiol 7:1382. doi:10.3389/fmicb.2016.01382.
    OpenUrlCrossRef
  3. 3.↵
    1. Warrilow AG,
    2. Parker JE,
    3. Price CL,
    4. Nes WD,
    5. Kelly SL,
    6. Kelly DE
    . 2015. In vitro biochemical study of CYP51-mediated azole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 59:7771–7778. doi:10.1128/AAC.01806-15.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Diaz-Guerra TM,
    2. Mellado E,
    3. Cuenca-Estrella M,
    4. Rodriguez-Tudela JL
    . 2003. A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 47:1120–1124. doi:10.1128/aac.47.3.1120-1124.2003.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Manavathu EK,
    2. Alangaden GJ,
    3. Chandrasekar PH
    . 2003. Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus. J Antimicrob Chemother 51:1423–1425. doi:10.1093/jac/dkg242.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Mellado E,
    2. Garcia-Effron G,
    3. Alcazar-Fuoli L,
    4. Cuenca-Estrella M,
    5. Rodriguez-Tudela JL
    . 2004. Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother 48:2747–2750. doi:10.1128/AAC.48.7.2747-2750.2004.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Garcia-Effron G,
    2. Dilger A,
    3. Alcazar-Fuoli L,
    4. Park S,
    5. Mellado E,
    6. Perlin DS
    . 2008. Rapid detection of triazole antifungal resistance in Aspergillus fumigatus. J Clin Microbiol 46:1200–1206. doi:10.1128/JCM.02330-07.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Umeyama T,
    2. Hayashi Y,
    3. Shimosaka H,
    4. Inukai T,
    5. Yamagoe S,
    6. Takatsuka S,
    7. Hoshino Y,
    8. Nagi M,
    9. Nakamura S,
    10. Kamei K,
    11. Ogawa K,
    12. Miyazaki Y
    . 2018. CRISPR/Cas9 genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 62:e00894-18. doi:10.1128/AAC.00894-18.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Camps SM,
    2. van der Linden JW,
    3. Li Y,
    4. Kuijper EJ,
    5. van Dissel JT,
    6. Verweij PE,
    7. Melchers WJ
    . 2012. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob Agents Chemother 56:10–16. doi:10.1128/AAC.05088-11.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Chowdhary A,
    2. Kathuria S,
    3. Xu J,
    4. Meis JF
    . 2013. Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog 9:e1003633. doi:10.1371/journal.ppat.1003633.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Fuhren J,
    2. Voskuil WS,
    3. Boel CH,
    4. Haas PJ,
    5. Hagen F,
    6. Meis JF,
    7. Kusters JG
    . 2015. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. J Antimicrob Chemother 70:2894–2898. doi:10.1093/jac/dkv177.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Snelders E,
    2. van der Lee HA,
    3. Kuijpers J,
    4. Rijs AJ,
    5. Varga J,
    6. Samson RA,
    7. Mellado E,
    8. Donders AR,
    9. Melchers WJ,
    10. Verweij PE
    . 2008. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 5:e219. doi:10.1371/journal.pmed.0050219.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Hodiamont CJ,
    2. Dolman KM,
    3. Ten Berge IJ,
    4. Melchers WJ,
    5. Verweij PE,
    6. Pajkrt D
    . 2009. Multiple-azole-resistant Aspergillus fumigatus osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery. Med Mycol 47:217–220. doi:10.1080/13693780802545600.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Escribano P,
    2. Recio S,
    3. Peláez T,
    4. Bouza E,
    5. Guinea J
    . 2011. Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole. Antimicrob Agents Chemother 55:2460–2462. doi:10.1128/AAC.01358-10.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Alanio A,
    2. Cabaret O,
    3. Sitterlé E,
    4. Costa JM,
    5. Brisse S,
    6. Cordonnier C,
    7. Bretagne S
    . 2012. Azole preexposure affects the Aspergillus fumigatus population in patients. Antimicrob Agents Chemother 56:4948–4950. doi:10.1128/AAC.05990-11.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. van der Linden JW,
    2. Arendrup MC,
    3. Warris A,
    4. Lagrou K,
    5. Pelloux H,
    6. Hauser PM,
    7. Chryssanthou E,
    8. Mellado E,
    9. Kidd SE,
    10. Tortorano AM,
    11. Dannaoui E,
    12. Gaustad P,
    13. Baddley JW,
    14. Uekötter A,
    15. Lass-Flörl C,
    16. Klimko N,
    17. Moore CB,
    18. Denning DW,
    19. Pasqualotto AC,
    20. Kibbler C,
    21. Arikan-Akdagli S,
    22. Andes D,
    23. Meletiadis J,
    24. Naumiuk L,
    25. Nucci M,
    26. Melchers WJ,
    27. Verweij PE
    . 2015. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis 21:1041–1044. doi:10.3201/eid2106.140717.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Bueid A,
    2. Howard SJ,
    3. Moore CB,
    4. Richardson MD,
    5. Harrison E,
    6. Bowyer P,
    7. Denning DW
    . 2010. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother 65:2116–2118. doi:10.1093/jac/dkq279.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Garcia-Rubio R,
    2. Alcazar-Fuoli L,
    3. Monteiro MC,
    4. Monzon S,
    5. Cuesta I,
    6. Pelaez T,
    7. Mellado E
    . 2018. Insight into the significance of Aspergillus fumigatus cyp51A polymorphisms. Antimicrob Agents Chemother 62:e00241-18. doi:10.1128/AAC.00241-18.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Dudakova A,
    2. Spiess B,
    3. Tangwattanachuleeporn M,
    4. Sasse C,
    5. Buchheidt D,
    6. Weig M,
    7. Groß U,
    8. Bader O
    . 2017. Molecular tools for the detection and deduction of azole antifungal drug resistance phenotypes in Aspergillus species. Clin Microbiol Rev 30:1065–1091. doi:10.1128/CMR.00095-16.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Bernal-Martínez L,
    2. Gil H,
    3. Rivero-Menéndez O,
    4. Gago S,
    5. Cuenca-Estrella M,
    6. Mellado E,
    7. Alastruey-Izquierdo A
    . 2017. Development and validation of a high-resolution melting assay to detect azole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 61:e01083-17. doi:10.1128/AAC.01083-17.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Toyotome T,
    2. Hagiwara D,
    3. Watanabe A,
    4. Kamei K
    . 2018. A simple method to detect the tandem repeat of the cyp51A promoter in azole-resistant strains of Aspergillus fumigatus. Med Mycol 56:1042–1044. doi:10.1093/mmy/myx149.
    OpenUrlCrossRef
  22. 22.↵
    1. Yu LS,
    2. Rodriguez-Manzano J,
    3. Malpartida-Cardenas K,
    4. Sewell T,
    5. Bader O,
    6. Armstrong-James D,
    7. Fisher MC,
    8. Georgiou P
    . 2019. Rapid and sensitive detection of azole-resistant Aspergillus fumigatus by tandem repeat loop-mediated isothermal amplification. J Mol Diagn 21:286–295. doi:10.1016/j.jmoldx.2018.10.004.
    OpenUrlCrossRef
  23. 23.↵
    1. Lee HB,
    2. Sebo ZL,
    3. Peng Y,
    4. Guo Y
    . 2015. An optimized TALEN application for mutagenesis and screening in Drosophila melanogaster. Cell Logist 5:e1023423. doi:10.1080/21592799.2015.1023423.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Bevacqua RJ,
    2. Fernandez-Martín R,
    3. Savy V,
    4. Canel NG,
    5. Gismondi MI,
    6. Kues WA,
    7. Carlson DF,
    8. Fahrenkrug SC,
    9. Niemann H,
    10. Taboga OA,
    11. Ferraris S,
    12. Salamone DF
    . 2016. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system. Theriogenology 86:1886–1896.e1. doi:10.1016/j.theriogenology.2016.06.010.
    OpenUrlCrossRef
  25. 25.↵
    1. Kang H,
    2. Minder P,
    3. Park MA,
    4. Mesquitta WT,
    5. Torbett BE,
    6. Slukvin II
    . 2015. CCR5 disruption in induced pluripotent stem cells using CRISPR/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus. Mol Ther Nucleic Acids 4:e268. doi:10.1038/mtna.2015.42.
    OpenUrlCrossRef
  26. 26.↵
    1. Voskarides K,
    2. Deltas C
    . 2009. Screening for mutations in kidney-related genes using SURVEYOR nuclease for cleavage at heteroduplex mismatches. J Mol Diagn 11:311–318. doi:10.2353/jmoldx.2009.080144.
    OpenUrlCrossRefPubMed
  27. 27.↵
    Clinical and Laboratory Standards Institute. 2017. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, M38, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA. https://clsi.org/standards/products/microbiology/documents/m38/.
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay
Teppei Arai, Hidetaka Majima, Akira Watanabe, Katsuhiko Kamei
Antimicrobial Agents and Chemotherapy Mar 2020, 64 (4) e02271-19; DOI: 10.1128/AAC.02271-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Simple Method To Detect Point Mutations in Aspergillus fumigatus cyp51A Gene Using a Surveyor Nuclease Assay
Teppei Arai, Hidetaka Majima, Akira Watanabe, Katsuhiko Kamei
Antimicrobial Agents and Chemotherapy Mar 2020, 64 (4) e02271-19; DOI: 10.1128/AAC.02271-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Aspergillus fumigatus
azole resistance
cyp51A

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596